Company news
Genedrive Plc (LSE:GDR) news
Genedrive Plc news releases on 6ix. Latest, Sep 10, 2026: Welsh hospitals extend routine MT-RNR1 testing
Press releases & updates
Welsh hospitals extend routine MT-RNR1 testing
September 10, 2026
ShareSoc Investor Presentation Reminder
September 3, 2026
Director/PDMR Notification
September 1, 2026
Board Appointments
August 21, 2026
ShareSoc Investor Presentation
August 13, 2026
Completion of PALOH-UK Patient Recruitment
August 11, 2026
MT-RNR1 test implemented in the Netherlands
August 4, 2026
New UK clinical guideline for MT-RNR1 testing
August 3, 2026
UK Minister highlights pharmacogenetic testing
July 10, 2026
Board change
July 1, 2026
CYP2C19 Agreement with Thermo Fisher Scientific
June 29, 2026
Manchester NHS Trust transitions MT-RNR1 to BAU
June 18, 2026
Board Changes
May 26, 2026
Sussex NHS Trust transitions MT-RNR1 test to BAU
May 5, 2026
NHS England commercial strategy for MT-RNR1
April 21, 2026
Interactive Investor Hub Updates
April 20, 2026
CYP2C19 kit implemented in North Bristol NHS Trust
April 16, 2026
Interim Results to 31 December 2025
March 30, 2026
Holding(s) in Company
March 12, 2026
Result of General Meeting
March 9, 2026
Publication of circular, notice of GM & timetable
February 19, 2026
Completion of Placing
February 13, 2026
Proposed equity raise of up to £6.0 million
January 19, 2026
Result of AGM
December 31, 2025
Scotland NHS “test of change” pilot programme
December 18, 2025
New interactive investor hub
December 11, 2025
Agreement of Shareholder Loan
December 9, 2025
Annual Report and Accounts and date of AGM
December 8, 2025
Final Results
December 5, 2025
Notice of Results
December 3, 2025
Block Listing Returns
December 1, 2025
NHS implementation guide published for CYP2C19
November 27, 2025
Scotland national roll-out of MT-RNR1 ID Kit
November 26, 2025
Further re Shareholder Loan
November 19, 2025
MT-RNR1 ID Kit in Dublin’s Rotunda Hospital
November 4, 2025
Potential Shareholder Loan
October 31, 2025
MOU with Kingdom of Saudi Arabia for MT-RNR1 ID
October 28, 2025
Application for Listing & Total Voting Rights
October 24, 2025
Further re Equity Financing
October 9, 2025
Publication of Circular and Notice of GM
September 29, 2025
Proposed Retail Offer
September 23, 2025
Proposed Share Capital Reorganisation & GM
August 29, 2025
Scotland’s Public Health Minister visit
August 21, 2025
Comment re: Share Price Movement
August 14, 2025
Trading update
August 11, 2025
CE-certification
May 30, 2025
CYP2C19-ID Kit used to support expansion
May 13, 2025
CYP2C19 ID Kit CE-IVD certification update
May 2, 2025
Additional grant funding under DEVOTE programme
April 2, 2025
Result of RetailBook Offer
April 1, 2025